Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dong Han

15PUBLICATIONS
0CO-AUTHORS
Epidemiological modellingFood properties (incl. characteristics and health benefits)Toxicology (incl. clinical toxicology)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Human biophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|May 20, 2026
Statins for the prevention of exacerbations in COPD: a systematic review and meta-analysis of randomized controlled trials.

|Nov 24, 2025
Thiamin supplementation on mitigating kidney injury and mortality in patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.

Guizuo Wang, Xu Liao, Yixing Liao

|Nov 19, 2025
Methylprednisolone versus dexamethasone in hospitalized patients with severe COVID-19: a systematic review and meta-analysis of randomized controlled trials.

Jinlv Qin, Guizuo Wang, Dong Han

|Sep 16, 2025
Benefits of Nanocurcumin on Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Wenli Shang, Guizuo Wang, Dong Han

|Jul 07, 2025
Is high flow nasal therapy still warranted for patients with AECOPD and acute hypercapnic respiratory failure?

Jinlv Qin, Guizuo Wang, Yixing Liao

|May 13, 2025
High flow nasal therapy versus noninvasive ventilation for AECOPD with acute hypercapnic respiratory failure: a meta-analysis of randomized controlled trials.

Jinlv Qin, Guizuo Wang, Yixing Liao

Pageof 3

Frequent Collaborators

Frequent Collaborators